| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |